Prime Medicine, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Prime Medicine, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Prime Medicine, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$55.3M, a 30.5% decline year-over-year.
  • Prime Medicine, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$217M, a 44.6% decline year-over-year.
  • Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$198M, a 62.6% decline from 2022.
  • Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$122M, a 26.3% increase from 2021.
  • Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$165M, a 4749% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$198M -$76.3M -62.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 -$122M +$43.5M +26.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$165M -$162M -4749% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$3.41M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.